NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Trailhead Biosystems Inc.

Trailhead Biosystems Inc.

Private
Beachwood, OhioHealthcare & Life Scienceshttps://trailbio.com/

Last Round

Financing

Jan 12, 2026

Total Funding Raised

$18.13M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Trailhead Biosystems Inc. is a biotechnology company that develops human cells with defined molecular and functional properties for drug discovery and regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

induced pluripotent stem cellsiPSCcell modelsdrug discoveryhematopoietic progenitor cellscell differentiationbiotech reagentstoxicology screeningdisease modelingregenerative medicinedesign of experimentsDoEbioinformaticscell therapy toolspreclinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Trailhead Biosystems Inc. Comps

Public and private peers based on sector, stage, and business model.

Trailhead Biosystems Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Trailhead Biosystems Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
FinancingJan 12, 2026
VC RoundMay 6, 2025
Series A ExtensionOct 11, 2022
Series ANov 10, 2020
GrantJan 24, 2018
Seed
Sep 22, 2016

Key People

Founding team and executive leadership

Div Trivedi

Chief Operating Officer

Executive Team

Trailhead Biosystems Inc. Investors

Notable investors and investment history

Trailhead Biosystems Inc. investors
InvestorRounds
Lorain County Community College Innovation FundSeed
MAK Capital OneVC Round, Financing
Innovation FundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 28, 2026

    TrailBio Endothelial Cells, an iPSC-derived vascular endothelium model, is now commercially available.

  • Aug 5, 2025

    Launched TrailBio Hematopoietic Progenitor Cells for cell model development.

Trailhead Biosystems Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Trailhead Biosystems Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Trailhead Biosystems Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeachwood, Ohio
Employee Range53
Year Founded2015
Last FundingJan 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.